EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: the mechanism and its implications in targeted therapy
出版年份 2018 全文链接
标题
EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: the mechanism and its implications in targeted therapy
作者
关键词
-
出版物
Cell Death & Disease
Volume 9, Issue 3, Pages -
出版商
Springer Nature
发表日期
2018-02-15
DOI
10.1038/s41419-018-0302-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Drosophila Lung Cancer Models Identify Trametinib plus Statin as Candidate Therapeutic
- (2016) Benjamin D. Levine et al. Cell Reports
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- YAP activates the Hippo pathway in a negative feedback loop
- (2015) Xiaoming Dai et al. CELL RESEARCH
- The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer
- (2015) S. Song et al. CLINICAL CANCER RESEARCH
- The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression
- (2015) Chunbo He et al. EMBO Molecular Medicine
- Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
- (2015) Georgina V Long et al. LANCET
- The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
- (2015) Luping Lin et al. NATURE GENETICS
- Advances in targeted therapies for hepatocellular carcinoma in the genomic era
- (2015) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
- (2014) Avnish Kapoor et al. CELL
- KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
- (2014) Diane D. Shao et al. CELL
- CD44 acts through RhoA to regulate YAP signaling
- (2014) Yuchen Zhang et al. CELLULAR SIGNALLING
- Significant Association of Oncogene YAP1 with Poor Prognosis and Cetuximab Resistance in Colorectal Cancer Patients
- (2014) K.-W. Lee et al. CLINICAL CANCER RESEARCH
- YAP activation is an early event and a potential therapeutic target in liver cancer development
- (2014) Andrea Perra et al. JOURNAL OF HEPATOLOGY
- Metabolic control of YAP and TAZ by the mevalonate pathway
- (2014) Giovanni Sorrentino et al. NATURE CELL BIOLOGY
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
- (2014) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer
- (2014) Fredrik Jerhammar et al. ORAL ONCOLOGY
- The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development
- (2013) Evan R Barry et al. CURRENT OPINION IN CELL BIOLOGY
- Regulation of Hippo Signaling by EGFR-MAPK Signaling through Ajuba Family Proteins
- (2013) B.V.V.G. Reddy et al. DEVELOPMENTAL CELL
- Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
- (2013) Bryan C. Fuchs et al. HEPATOLOGY
- Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility
- (2013) Z. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1
- (2013) R. Fan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells
- (2013) J Chen et al. Cell Death & Disease
- Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
- (2012) Mary Maluccio et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
- (2012) Fa-Xing Yu et al. CELL
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- Reduced Risk of Colorectal Cancer With Use of Oral Bisphosphonates: A Systematic Review and Meta-Analysis
- (2012) Nirav Thosani et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Statin Use and Reduced Cancer-Related Mortality
- (2012) Sune F. Nielsen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation
- (2011) Raquel Urtasun et al. HEPATOLOGY
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
- (2009) Dawang Zhou et al. CANCER CELL
- Statins potentiate cytostatic/cytotoxic activity of sorafenib but not sunitinib against tumor cell lines in vitro
- (2009) Jacek Bil et al. CANCER LETTERS
- Pathogenesis of hepatocellular carcinoma and molecular therapies
- (2009) Beatriz Mínguez et al. CURRENT OPINION IN GASTROENTEROLOGY
- Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
- (2009) Hashem B. El–Serag et al. GASTROENTEROLOGY
- YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway
- (2009) Jianmin Zhang et al. NATURE CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now